Rebecca Bishop
Cancer Research UK Clinical Trials Unit(GB)University of Birmingham(GB)Clemson University(US)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, Acute Lymphoblastic Leukemia research, Lymphoma Diagnosis and Treatment, Hematopoietic Stem Cell Transplantation
Most-Cited Works
- → Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study(2019)266 cited
- → Global gene expression analysis of apple fruit development from the floral bud to ripe fruit(2008)236 cited
- → Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial(2021)52 cited
- → A multi‐centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T‐prolymphocytic leukaemia or mantle cell lymphoma(2017)33 cited
- → Initial Results of Ibrutinib Plus Venetoclax in Relapsed, Refractory CLL (Bloodwise TAP CLARITY Study): High Rates of Overall Response, Complete Remission and MRD Eradication after 6 Months of Combination Therapy(2017)33 cited
- → Ibrutinib Plus Venetoclax in Relapsed/Refractory CLL: Results of the Bloodwise TAP Clarity Study(2018)31 cited